Adolor Corp. Gets Approvable Letter

Today Adolor Corp. announced receipt of an approvable letter from the FDA requesting 12-month safety data that includes an analysis of any cardiovascular related adverse events.  The application was for Entereg, indicated for the management of postoperative ileus. 

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
This entry was posted in Clinical Trials. Bookmark the permalink.

Comments are closed.